Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Study of Venetoclax in Combination With Cytotoxic Chemotherapy, Including Calaspargase Pegol, for Children, Adolescents and Young Adults With High-Risk Hematologic Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05292664
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:14.248902+00:00
Published At
2026-03-12T00:00:00+00:00
Record Updated At
2026-03-12
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Myelodysplastic Syndromes, de Novo", "Myelodysplastic Syndromes, Secondary", "Myelodysplastic Syndromes, Previously Treated", "Treatment-Related Acute Myeloid Leukemia", "Therapy-Related Myelodysplastic Syndrome", "Acute Lymphoblastic Leukemia, in Relapse", "Acute Lymphoblastic Leukemia With Failed Remission", "Lymphoblastic Lymphoma, in Relapse", "Lymphoblastic Lymphoma, Refractory", "Acute Leukemia of Ambiguous Lineage in Relapse", "Acute Leukemia of Ambiguous Lineage"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-03-12"
protocolSection.identificationModule.nctId
"NCT05292664"
protocolSection.identificationModule.officialTitle
"A Phase I Study of Venetoclax in Combination With Cytotoxic Chemotherapy, Including Calaspargase Pegol, for Children, Adolescents and Young Adults With High-Risk Hematologic Malignancies"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Myelodysplastic Syndromes, de Novo (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndromes, Secondary (protocolSection.conditionsModule.conditions)
  • Myelodysplastic Syndromes, Previously Treated (protocolSection.conditionsModule.conditions)
  • Treatment-Related Acute Myeloid Leukemia (protocolSection.conditionsModule.conditions)
  • Therapy-Related Myelodysplastic Syndrome (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia, in Relapse (protocolSection.conditionsModule.conditions)
  • Acute Lymphoblastic Leukemia With Failed Remission (protocolSection.conditionsModule.conditions)
  • Lymphoblastic Lymphoma, in Relapse (protocolSection.conditionsModule.conditions)
  • Lymphoblastic Lymphoma, Refractory (protocolSection.conditionsModule.conditions)
  • Acute Leukemia of Ambiguous Lineage in Relapse (protocolSection.conditionsModule.conditions)
  • Acute Leukemia of Ambiguous Lineage (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.